Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Jan;68(1):88-90.
doi: 10.1136/adc.68.1.88.

Secondary thrombocytosis

Affiliations

Secondary thrombocytosis

A J Vora et al. Arch Dis Child. 1993 Jan.

Abstract

To estimate the incidence and causes of secondary thrombocytosis in children, a 12 month study of all patients attending a children's hospital and discovered to have a platelet count over two times the upper normal limit (> 800 x 10(9)/l) was undertaken. Data so obtained were analysed both separately and together with those from two previous studies to gain as broad a perspective as possible. Of 7916 children who had platelet counts during the study period, 36 (0.5%) produced a value > 800 x 10(9)/l; there were 19 boys and 17 girls. There was a preponderance of young infants (median age 13 months). Twenty seven of the 36 had some sort of associated infection, bacterial in 18 and viral in nine. The other nine were either recovering from anti-neoplastic chemotherapy (n = 6), were post-operative (n = 2), or simply iron deficient (n = 1). Combining these patients with those described in previous studies allowed a review of 139 unselected children with very high platelet counts. Fifty three (38%) had infections, 29 (20%) had traumatic or surgical tissue damage, 16 (11%) had malignant disease undergoing chemotherapy or surgery, and 13 (9%) had connective tissue or autoimmune disorders. Secondary thrombocytosis is not rare and is most frequently seen in very young infants after infection. It can arise in a wide variety of other circumstances including rebound from myelosuppression, iron lack, or as part of an acute phase response. It is clinically unimportant in terms of morbidity and requires no treatment other than that for the primary condition.

PubMed Disclaimer

Comment in

  • Secondary thrombocytosis.
    De Benedetti F, Martini A. De Benedetti F, et al. Arch Dis Child. 1993 Jul;69(1):170-1. doi: 10.1136/adc.69.1.170-c. Arch Dis Child. 1993. PMID: 8024310 Free PMC article. No abstract available.
  • Extreme thrombocytosis as a diagnostic clue to hepatoblastoma.
    Shafford EA, Pritchard J. Shafford EA, et al. Arch Dis Child. 1993 Jul;69(1):171. doi: 10.1136/adc.69.1.171. Arch Dis Child. 1993. PMID: 8024312 Free PMC article. No abstract available.

References

    1. Am J Med Sci. 1991 Jan;301(1):69-80 - PubMed
    1. Pediatrics. 1964 Sep;34:315-23 - PubMed
    1. Pediatrics. 1989 Dec;84(6):1064-7 - PubMed
    1. Am J Clin Pathol. 1973 Feb;59(2):243-7 - PubMed
    1. J Pediatr. 1974 Dec;85(6):805-7 - PubMed

LinkOut - more resources